Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Revenue
Expenses:
Research and development	772,702	279,489
General and administrative	2,844,728	3,532,302
Depreciation and amortization	5,712	11,835
Total operating expenses	3,623,142	3,823,626
Loss from operations	(3,623,142)	(3,823,626)
Other income (expense):
Interest income	33,457	55,434
Sale of royalty and milestone rights, net of transaction costs	2,000,000	4,167,219
Other income (expense), net		1,416
Net income (loss)	(1,589,685)	400,443
Dividends paid on preferred shares		(68,809)
Net income (loss) attributable to common stockholders	$ (1,589,685)	$ 331,634
Basic income (loss) per share	$ (3.21)	$ 0.68
Diluted income (loss) per share	$ (3.21)	$ 0.68
Basic weighted average shares outstanding	495,092	488,392
Diluted weighted average shares outstanding	495,092	488,392